Perrigo Company PLC (NYSE:PRGO)

64.29
BATS BZX Real-Time Price
As of 10:08am ET
 -1.10 / -1.68%
Today’s Change
62.75
Today|||52-Week Range
95.93
-26.24%
Year-to-Date
Weekly CEO Buys Highlight
Nov 12 / GuruFocus News - Paid Partner Content
Stocks Sink Waiting for Fed's Statement
Nov 08 / GuruFocus News - Paid Partner Content
Stocks That Fell to 3-Year Lows in the Week of Nov. 9
Nov 11 / GuruFocus News - Paid Partner Content
Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down
Nov 08 / Zacks.com - Paid Partner Content
Perrigo Co Plc (PRGO) CEO Murray S Kessler Bought $1 million of Shares
Nov 09 / GuruFocus News - Paid Partner Content
Perrigo (PRGO) Q3 Earnings Beat Estimates
Nov 08 / Zacks.com - Paid Partner Content
3 Stocks Move Thursday
Nov 08 / GuruFocus News - Paid Partner Content
What's in the Cards for Perrigo (PRGO) This Earnings Season?
Nov 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close65.39
Today’s open65.27
Day’s range64.17 - 65.27
Volume7,104
Average volume (3 months)1,559,183
Market cap$8.9B
Data as of 10:08am ET, 11/14/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-6.23%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-6.34%
P/E ratio74.2
Price/Sales2.51
Price/Book1.49

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.53-0.97%
JAZZJazz Pharmaceuticals...-3.12-2.07%
SRPTSarepta Therapeutics...-2.25-1.93%
IONSIonis Pharmaceutical...-0.08-0.15%
Data as of 10:07am ET, 11/14/2018

Financials

Next reporting dateFebruary 14, 2019
EPS forecast (this quarter)$1.37
Annual revenue (last year)$4.9B
Annual profit (last year)$119.6M
Net profit margin2.42%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Murray S. Kessler
Executive VP-
Global Operations and Supply Chain
Ronald Janish
Corporate headquarters
Dublin, Dublin

Forecasts